Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
F5
FFIV
$23.2B
| $5.97M | ﹤0.01% |
40,826
-90,069
| -69% | -$12.8M |
|
2452
Novartis
NVS
$294B
| $5.97M | ﹤0.01% |
59,154
-888,068
| -94% | -$88.8M |
|
2453
PUT
ArcelorMittal
MT
$56.3B
| $5.96M | ﹤0.01% |
218,000
+174,800
| +405% | +$4.8M |
|
2454
Vuzix
VUZI
$221M
| $5.96M | ﹤0.01% |
1,168,510
+1,041,430
| +820% | +$4.61M |
|
2455
iShares TIPS Bond ETF
TIP
$15.1B
| $5.95M | ﹤0.01% |
55,303
+30,543
| +123% | +$3.33M |
|
2456
Community Health Systems
CYH
$413M
| $5.94M | ﹤0.01% |
1,350,938
+1,145,544
| +558% | +$4.88M |
|
2457
Center Bancorp
CNOB
$1.61B
| $5.94M | ﹤0.01% |
358,102
+225,731
| +171% | +$3.52M |
|
|
CGAU
2458
Centerra Gold
CGAU
$4.74B
| $5.94M | ﹤0.01% |
990,202
-642,781
| -39% | -$4.08M |
|
|
SVII
2459
DELISTED
Spring Valley Acquisition Corp II
SVII
| $5.93M | ﹤0.01% |
562,000
-480,000
| -46% | -$5.02M |
|
2460
Alaska Air
ALK
$4.71B
| $5.93M | ﹤0.01% |
111,445
+8,010
| +8% | +$364K |
|
2461
Pegasystems
PEGA
$5.9B
| $5.92M | ﹤0.01% |
240,258
-753,706
| -76% | -$17.5M |
|
2462
PUT
Exelon
EXC
$45.3B
| $5.91M | ﹤0.01% |
145,100
-253,600
| -64% | -$10.5M |
|
2463
PUT
HP
HPQ
$27.1B
| $5.91M | ﹤0.01% |
192,300
+38,100
| +25% | +$1.14M |
|
|
OLO
2464
DELISTED
Olo Inc
OLO
| $5.89M | ﹤0.01% |
912,208
+586,115
| +180% | +$4.22M |
|
|
GFGD
2465
DELISTED
The Growth for Good Acquisition Corporation Class A Ordinary Shares
GFGD
| $5.89M | ﹤0.01% |
564,000
| – | – |
|
|
SHOE
2466
Shoe Station Group
SHOE
$376M
| $5.89M | ﹤0.01% |
250,751
-529,083
| -68% | -$12.1M |
|
|
IVCA
2467
DELISTED
Investcorp India Acquisition Corp
IVCA
| $5.88M | ﹤0.01% |
550,000
| – | – |
|
|
RPT
2468
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $5.88M | ﹤0.01% |
562,942
+257,274
| +84% | +$2.44M |
|
2469
C4 Therapeutics
CCCC
$504M
| $5.87M | ﹤0.01% |
2,135,597
+1,982,041
| +1,291% | +$6.37M |
|
2470
Franklin Covey
FC
$230M
| $5.87M | ﹤0.01% |
134,291
-152,088
| -53% | -$5.63M |
|
2471
Afya
AFYA
$1.27B
| $5.86M | ﹤0.01% |
417,552
-305,251
| -42% | -$3.74M |
|
|
SRG
2472
CALL
Seritage Growth Properties
SRG
$117M
| $5.86M | ﹤0.01% |
+656,500
| New | +$5.25M |
|
2473
LSB Industries
LXU
$752M
| $5.84M | ﹤0.01% |
592,810
-8,765
| -1% | -$83.9K |
|
2474
Vaalco Energy
EGY
$607M
| $5.84M | ﹤0.01% |
1,552,772
+194,414
| +14% | +$793K |
|
2475
Affirm
AFRM
$26B
| $5.83M | ﹤0.01% |
380,531
+48,580
| +15% | +$644K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.